Mednet Logo
HomePediatric Hematology/OncologyQuestion

How do you counsel families of pediatric patients regarding risk of secondary malignancy or IQ changes with cranial radiation using photons?

1 Answers
Mednet Member
Mednet Member
Radiation Oncology · St Jude Children's Research Hospital

It’s a great question as these are two of the scariest things that families face when you relay the potential risks of cranial radiotherapy. Simple things like timing of these topics in the consent discussion can make a difference. Don’t start with the scariest potential risk when doing the consent,...

Register or Sign In to see full answer

How do you counsel families of pediatric patients regarding risk of secondary malignancy or IQ changes with cranial radiation using photons? | Mednet